Literature DB >> 9924427

Frequent p53 gene mutations in serrated adenomas of the colorectum.

T Hiyama1, H Yokozaki, F Shimamoto, K Haruma, W Yasui, G Kajiyama, E Tahara.   

Abstract

Serrated adenoma has been recently proposed as a distinct histological lesion of the colorectum. This study examined p53 immunoreactivity, mutations of exons 5-8 of the p53 gene, codon 12 of the Ki-ras gene by PCR-SSCP analyses, and microsatellite instability in 19 serrated adenomas, ten adenocarcinomas in/with serrated adenomas, 23 hyperplastic nodules, four hyperplastic polyps and 29 tubular adenomas of the colorectum. Eleven of 11 (100 per cent) serrated adenomas had p53 immunoreactivity and all six (100 per cent) adenocacinomas in/with serrated adenomas exhibited moderate to severe p53 immunoreactivity. It was confirmed that 9 of 19 (47 per cent) serrated adenomas and 5 of 10 (50 per cent) adenocarcinomas in/with serrated adenomas harboured p53 gene mutations. On the other hand, no p53 gene mutation was detected in the other colorectal lesions. Meanwhile, 11 (58 per cent) serrated adenomas and six (60 per cent) adenocarcinomas in/with serrated adenomas had Ki-ras gene mutations, as also did 9 of 23 (39 per cent) hyperplastic nodules, 3 of 4 (75 per cent) hyperplastic polyps, and 12 of 29 (41 per cent) tubular adenomas. Microsatellite instability was detected in one (5 per cent) serrated adenoma and one (10 per cent) adenocarcinoma in a serrated adenoma. The other lesions did not show microsatellite instability. Serrated adenomas had significantly frequent p53 gene mutations compared with hyperplastic lesions or tubular adenomas (p < 0.005). On the other hand, they did not exhibit significant differences in mutations of the Ki-ras gene or in microsatellite instability. Genetic changes were then examined in small parts of serrated adenomas, such as the upper or lower parts of crypts, to determine the extent of gene mutations by using a microdissection technique. Exon 15 of the APC gene and the DCC gene, in addition to the p53 and Ki-ras genes and microsatellite instability, were analysed. Identical mutations of the p53 gene were found in both invasive adenocarcinomas and adjacent serrated adenomas by direct sequencing, suggesting single clonal origins for those lesions. Mutations of the APC gene and microsatellite instability were heterogeneous in some lesions. No loss of heterozygosity (LOH) of the DCC gene was found. These findings suggest that mutations of the p53 gene are the most characteristic genetic alterations in serrated adenomas, as a relatively early event in a multistep carcinogenic pathway of this type of colorectal lesion, that might be distinct from the ordinary adenoma-carcinoma sequence or from carcinogenesis via mutations of mismatch repair genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924427     DOI: 10.1002/(SICI)1096-9896(1998100)186:2<131::AID-PATH158>3.0.CO;2-1

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

1.  Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway.

Authors:  N J Hawkins; P Gorman; I P Tomlinson; P Bullpitt; R L Ward
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma.

Authors:  Nye-Thane Ngo; Emile Tan; Paris Tekkis; David Peston; Patrizia Cohen
Journal:  Int J Colorectal Dis       Date:  2010-07-17       Impact factor: 2.571

3.  Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon.

Authors:  Baojin Fu; Shinichi Yachida; Richard Morgan; Yi Zhong; Elizabeth A Montgomery; Christine A Iacobuzio-Donahue
Journal:  Am J Clin Pathol       Date:  2012-09       Impact factor: 2.493

4.  The role of APC in WNT pathway activation in serrated neoplasia.

Authors:  Jennifer Borowsky; Troy Dumenil; Mark Bettington; Sally-Ann Pearson; Catherine Bond; Lochlan Fennell; Cheng Liu; Diane McKeone; Christophe Rosty; Ian Brown; Neal Walker; Barbara Leggett; Vicki Whitehall
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

5.  Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.

Authors:  J R Jass; K G Biden; M C Cummings; L A Simms; M Walsh; E Schoch; S J Meltzer; C Wright; J Searle; J Young; B A Leggett
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

6.  Clinico-pathological aspects of colorectal serrated adenomas.

Authors:  Ashish Chandra; Adnan A Sheikh; Anton Cerar; Ian C Talbot
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

7.  Frequent CpG island methylation in serrated adenomas of the colorectum.

Authors:  Seun-Ja Park; Asif Rashid; Jae-Hyuk Lee; Sang Geol Kim; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

8.  Different apoptotic activity and p21(WAF1/CIP1), but not p27(Kip1), expression in serrated adenomas as compared with traditional adenomas and hyperplastic polyps of the colorectum.

Authors:  Hiroyuki Mitomi; Miwa Sada; Kiyonori Kobayashi; Masahiro Igarashi; Akio Mori; Hideki Kanazawa; Yasuhiko Nishiyama; Atsushi Ihara; Yoshimasa Otani
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

9.  Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.

Authors:  Shinichi Mukai; Toru Hiyama; Shinji Tanaka; Masaharu Yoshihara; Koji Arihiro; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

10.  Molecular characteristics of serrated adenomas of the colorectum.

Authors:  E J Sawyer; A Cerar; A M Hanby; P Gorman; M Arends; I C Talbot; I P M Tomlinson
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.